These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35185060)

  • 1. Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia.
    Tanaka K; Koseki M; Kato H; Miyashita K; Okada T; Kanno K; Saga A; Chang J; Omatsu T; Inui H; Ohama T; Nishida M; Yamashita S; Sakata Y
    J Atheroscler Thromb; 2023 Jan; 30(1):100-104. PubMed ID: 35185060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease.
    Nozue T; Tada H; Murakami M; Michishita I
    J Clin Lipidol; 2023; 17(1):68-72. PubMed ID: 36402671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary hyperchylomicronemia].
    Yamashita S
    Nihon Rinsho; 2013 Sep; 71(9):1578-83. PubMed ID: 24205717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency.
    Rodríguez-Gutiérrez PG; Colima-Fausto AG; Zepeda-Olmos PM; Hernández-Flores TJ; González-García JR; Magaña-Torres MT
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
    Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene.
    Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S
    J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
    Strøm TB; Tveita AA; Bogsrud MP; Leren TP
    J Clin Lipidol; 2024; 18(1):e80-e89. PubMed ID: 37981531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL.
    Larsson M; Allan CM; Jung RS; Heizer PJ; Beigneux AP; Young SG; Fong LG
    J Lipid Res; 2017 Sep; 58(9):1893-1902. PubMed ID: 28694296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
    Chokshi N; Blumenschein SD; Ahmad Z; Garg A
    J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of lipoprotein lipase in complex with GPIHBP1.
    Arora R; Nimonkar AV; Baird D; Wang C; Chiu CH; Horton PA; Hanrahan S; Cubbon R; Weldon S; Tschantz WR; Mueller S; Brunner R; Lehr P; Meier P; Ottl J; Voznesensky A; Pandey P; Smith TM; Stojanovic A; Flyer A; Benson TE; Romanowski MJ; Trauger JW
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10360-10365. PubMed ID: 31072929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.
    Silbernagel G; Chen YQ; Rief M; Kleber ME; Hoffmann MM; Stojakovic T; Stang A; Sarzynski MA; Bouchard C; März W; Qian YW; Scharnagl H; Konrad RJ
    Eur Heart J; 2023 Jul; 44(25):2335-2345. PubMed ID: 37155355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
    Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
    J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
    Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
    J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
    Xie SL; Chen TZ; Huang XL; Chen C; Jin R; Huang ZM; Zhou MT
    PLoS One; 2015; 10(6):e0129488. PubMed ID: 26079787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
    Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.
    Serveaux Dancer M; Di Filippo M; Marmontel O; Valéro R; Piombo Rivarola MDC; Peretti N; Caussy C; Krempf M; Vergès B; Mahl M; Marçais C; Moulin P; Charrière S
    J Clin Lipidol; 2018; 12(5):1244-1252. PubMed ID: 30037590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.
    Allan CM; Larsson M; Hu X; He C; Jung RS; Mapar A; Voss C; Miyashita K; Machida T; Murakami M; Nakajima K; Bensadoun A; Ploug M; Fong LG; Young SG; Beigneux AP
    J Lipid Res; 2016 Oct; 57(10):1889-1898. PubMed ID: 27494936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
    Kassner U; Salewsky B; Wühle-Demuth M; Szijarto IA; Grenkowitz T; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Eur J Hum Genet; 2015 Sep; 23(9):1259-61. PubMed ID: 25585702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence.
    Chyzhyk V; Kozmic S; Brown AS; Hudgins LC; Starc TJ; Davila AD; Blevins TC; Diffenderfer MR; He L; Geller AS; Rush C; Hegele RA; Schaefer EJ
    J Clin Lipidol; 2019; 13(1):89-99. PubMed ID: 30352774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of GPIHBP1 causing severe chylomicronemia.
    Rios JJ; Shastry S; Jasso J; Hauser N; Garg A; Bensadoun A; Cohen JC; Hobbs HH
    J Inherit Metab Dis; 2012 May; 35(3):531-40. PubMed ID: 22008945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.